NIFTY PHARMA INDEX IS UNDER CONSOLIDATION ZONE AND WE CAN SEE SOME MAJOR SHORTS BUILDUP IN PHARMA STOCKS..DIVIS LAB CAN BE A GOOD SHORTING CANDIDATE FOR SHORT TERM GAINS AS IT HAS CLOSED BELOW IT'S 50DMA WHICH WILL LEADS TO MORE BEARISHNESS IN THE STOCK..THE INDICATORS ARE SHOWING SOME MORE BEARISHNESS IN THE STOCK..